Covid-19 may be Linked to The Risk of A Rare Paralysis-Inducing Disorder
According to a study released today, infection with the virus that causes COVID-19 may increase the risk of getting Guillain-Barre syndrome, a rare illness in which the immune system attacks the nerves, producing muscle weakness and occasionally paralysis.
Researchers and public health officials have reported neurological issues connected to COVID-19, in addition to the well-known severe respiratory indications and the potential of long-term consequences.
Guillain-Barre syndrome (GBS), an autoimmune disorder that can last weeks or years, is a rare but serious condition. An acute bacterial or viral infection causes the syndrome.
“Our findings show that COVID-19 may, in rare cases, precede Guillain-Barre syndrome,” stated Bart C Jacobs of the University Medical Center Rotterdam in the Netherlands.
“However, the presence of a true link or causal relationship must yet be demonstrated,” one of the paper’s authors, Jacobs, stated.
Over 90 cases of Guillain-Barre syndrome have been diagnosed as a result of a potential COVID-19 infection since the outbreak began.
The researchers say it’s unknown whether COVID-19 is another possible viral trigger or whether the observed cases are coincidental.
Researchers investigated patients from January 30 to May 30, 2020, using an international collection of Guillain-Barre syndrome patients known as the International GBS Outcome Study (or IGOS).
During this time, the study enrolled 49 new Guillain-Barre syndrome patients from China, Denmark, France, Greece, Italy, the Netherlands, Spain, Switzerland, and the United Kingdom.
According to the researchers, 22% of the Guillain-Barre syndrome patients included in this study, which was published in the journal Brain, had a previous COVID-19 infection within the first four months of the pandemic.
These patients were all over 50 years old, and they frequently (65%) had facial palsy (64%) and had a demyelination form of GBS, according to the researchers.
According to the study, 73 percent of Guillain-Barre patients with a COVID-19 infection had elevated inflammatory markers at the time of admission to the hospital.
All of these patients met both the Guillain-Barre syndrome and COVID-19 diagnostic criteria.
The researchers did observe, however, that throughout the first four months of the epidemic, they did not detect any more patients with Guillain-Barre syndrome than in previous years.
This shows that, while a substantial link between a COVID-19 infection and Guillain-Barre syndrome is unlikely, a COVID-19 infection may lead to the development of the disorder in certain patients, they added.
Apart from this, you can also read Entertainment, Tech, and Health-related articles here: Rainbow Kiss, MovieRulz, Sex Education season 3, NFL Live Stream, Youtbe, Bailey Sarian Net Worth, Bollyshare, Afdah, Samsung Galaxy F22 Review, 1616 Angel Number, 444 Angel Number, Moviezwap, Y8, Jalshamoviez, Website traffic checker, Project Free TV, Kickassanime, 777 Angel Number, September 8 Zodiac, Kissasian, 666 Angel Number, 333 Angel Number, Holiday Season, Samsung Galaxy Z Flip 3 review, PUBG Launch Date in India, Sears Credit Card, GoDaddy Email, Free Fire Redeem Code, Mangago, Jio Rockers, New iPhone 13, Vivo Y53s Review, Eye Shapes, M4uHD, Fever Dream, Moon water, iPhone Headphones, Spanish Movies, Hip dips, M4ufree, NBAstreams XYZ, CCleaner Browser review, Avocado Calories, Bear Grylls net worth, Rihanna net worth 2021, Highest Paid CEO, The 100 season 8, Sundar Pichai net worth, Grimes net worth, F95Zone, how to change Twitch name, Sherlock Season 5, Homeland Season 9.
To Read Our Exclusive Content, Sign up Now.
$5/Monthly, $50/Yearly
